ArticleFrontiers in oncology2023

Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors.

Xingzhi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.